EUROArray HSV VZV

New EUROArray detects and differentiates HSV-1/-2 and VZV

The EUROArray HSV1/2 VZV from EUROIMMUN provides direct detection and differentiation of herpes simplex viruses type 1 (HSV-2) and type 2 (HSV-2) and varicella zoster virus (VZV) from skin, mouth or genital swabs. It enables simple and fast distinction between the pathogens, especially in cases that are difficult to tell apart clinically. HSV-1 and HSV-2 […]

ziathpr44

Ziath wins Queen’s Award for Enterprise

Ziath has been awarded with a prestigious Queen’s Award for Enterprise (2022) in the International Trade category. 

proteonic

ProteoNic and NecstGen establish partnership to improve viral vector manufacturing efficiency for gene therapies

ProteoNic, a leading provider of premium vector technology and services for efficient production of biologics, and NecstGen, a CDMO and centre of excellence for cell and gene therapy, will partner to improve viral vector manufacturing for gene therapy applications. Both companies, located on the Leiden Bio Science Park, recognise the need to increase viral titres […]

vetter xpert alliance

Rentschler Biopharma, Vetter unveil Xpert Alliance, a joint visualization of their collaboration

Rentschler Biopharma and Vetter, two globally operating Contract Development and Manufacturing Organizations (CDMOs), are unveiling Xpert Alliance, a joint visualization of their strategic collaboration. The visualization is designed to “bring to life” this ongoing alliance and celebrate its successful operation, delivering effective solutions to address clients’ changing and expanding needs in the area of complex […]

keen eye ultivue

Keen Eye and Ultivue collaborate to advance multiplex and spatial analysis in clinical research

Keen Eye, a leading AI company in digital pathology for clinical research and Ultivue, an industry leader in multiplexing tools and novel image analysis solutions for tissue biomarker studies, will collaborate to promote multiplexed immunofluorescence (mIF) assays and scalable AI applications to unlock spatial analysis in clinical research.

horiba QSP

HORIBA introduces network option for digital morphology training tool for multiple user access in multiple locations

HORIBA UK has introduced a new network licence option for its QSP 2.0 (Quality Slide Program) [1] affordable digital tool for skill evaluation and training in morphology at IBMS Congress 2022. This now enables up to 50 users across various locations, even in different countries, to directly access this valuable digital morphology resource as it […]

cytena

CYTENA and ExcellGene to develop automated work-flows for biotherapeutics cell line development

CYTENA, a BICO group company and a leading provider of high-precision instruments for handling biological cells, will collaborate with ExcellGene, a leading biologics Contract Development & Manufacturing Organizations (CDMO) that manufactures recombinant proteins, to streamline cell line development workflows for highly-efficient monoclonal antibody (mAb) and complex therapeutic protein manufacturing, which enables important improvements to the […]

codexis seqwell

Codexis and seqWell announce partnership to accelerate commercialization of seqWell’s genomics workflow solutions

Codexis and seqWell have announced the initiation of a strategic partnership and investment to accelerate the commercialization of seqWell’s genomics workflow solutions. Codexis, a leading enzyme engineering company enabling the promise of synthetic biology, and seqWell, a developer of transformative library preparation products for demanding genomics applications, plan to collaborate on using Codexis’ CodeEvolver platform […]

biotium 5 22

Biotium acquires CAT5 FFPE RNA/DNA extraction technology from Cell Data Sciences

Biotium, a supplier of cutting-edge life science reagents, has acquired Cell Data Sciences RNAstorm and DNAstorm kits for RNA/DNA extraction. Biotium, which previously distributed the Cell Data Sciences kits, will now be their sole manufacturer. The extraction kits will be offered from the Biotium website and authorized distributors.

Arctoris

Arctoris and Evariste Technologies form a joint venture to identify novel small molecule cMET Inhibitors for Non-Small Cell Lung Cancer

Arctoris, a tech-enabled biopharma company, and Evariste Technologies, an AI-drug discovery company, have formed a joint venture to identify novel small molecule kinase inhibitors for treatment of patients with Non-Small Cell Lung Cancer (NSCLC).